Japan's Takeda aims to become carbon neutral by 2040

Japan-based Takeda Pharmaceutical Company Limited (TYO:4502) has unveiled its strategy to become carbon neutral by 2040, including entering renewable energy power purchase agreements (PPAs).

By 2040, the company intends to eliminate all greenhouse gas emissions from its operations and work with suppliers to cut their emissions by 50% from fiscal 2018 levels, while also using verified carbon offsets for the remaining emissions. This was announced at the 38th Annual JP Morgan Healthcare Conference on January 14.

In addition, Takeda plans to cut greenhouse gas emissions from its operations by 40% by 2025 from fiscal year 2016 levels. To achieve this, it plans to buy renewable energy, including through large-scale PPAs, while also implementing an internal energy management programme. By 2025, its suppliers' emissions have to be 15% lower than 2018 levels.

The company said it has already reached its 2020 target of cutting carbon dioxide (CO2) emissions by 33.7% from 2005 levels earlier than expected.

Choose your newsletter by Renewables Now. Join for free!